-
Amphora, under development by Evofem of San Diego, is a bioadhesive acid-buffering gel that coats the vaginal wall and cervix. Amphora helps maintain a woman's natural pH level between 3.8 and 4.2.
-
Trichomoniasis is the most common curable sexually transmitted infection (STI) in young, sexually active women, according to the Centers for Disease Control and Prevention. An estimated 7.4 million new cases occur each year in U.S. women and men.
-
Four hundred thousand (1.6% of U.S. adolescents) experience serious physical and/or sexual dating violence each year.
-
Since results of the 2002 Women's Health Initiative (WHI) report suggested that use of menopausal hormone therapy increases risk of coronary heart disease, science has examined the timing of therapy initiation on safe use of such treatment.
-
Is your facility participating in National HIV Testing Day on June 27? If not, you may be missing an important community outreach opportunity to help people learn their HIV status.
-
The investigators prospectively enrolled and followed a cohort of 97 teens before and six, 12, and 18 months after starting DMPA.
-
The latest figure for the rate of preterm birth (PTB) in the United States is 12.7%, which represents a rise of more than 20% since 1980, despite concerted efforts to address the problem.
-
Endometriosis is a common disorder in reproductive-age women and has been associated with an increased risk for development of invasive ovarian cancer.
-
The investigators prospectively enrolled and followed a cohort of 97 teenagers before, and 6, 12, and 18 months after starting depot medroxyprogesterone acetate (DMPA).
-
Among 701 women with chronic pelvic pain (CPP), 22% were affected by clinical depression. After undergoing either surgery (including hysterectomy) or non-surgical alternatives, response to the therapy was found to be independent of the presence of depression.
